Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery

Sponsor
Jena University Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05315596
Collaborator
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán (Other), Centro Medico Nacional Siglo XXI IMSS (Other), Hospital de Traumatología y Ortopedia Lomas Verdes (Other), Hospital Angeles Puebla (Other), Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo (Other), Hospital Angeles Lomas (Other), Hospital San Javier Guadalajara (Other), Hospital Aranda de La Parra (Leon Guanajuato) (Other), Fundación Clínica Médica Sur (Other), Instituto Nacional de Cancerologia de Mexico (Other), Hospital General Dr. Ruben Leñero (Other), Hospital Central "Dr. Ignacio Morones Prieto" (Other), Hospital General Regional Número 2 Dr. Guillermo Fajardo Ortiz (Other), Instituto Nacional de Enfermedades Respiratorias (Other), Hospital Central Militar (Other)
1,000
16
106.9
62.5
0.6

Study Details

Study Description

Brief Summary

Little is known about pain-related outcomes experienced by patients in the first few weeks after surgery, once they are discharged from hospital.

This study aims to characterize pain, pain-related interference, and early neuropathic pain in the sub-acute phase after surgery.

Detailed Description

A high proportion of patients experience moderate to severe pain after surgery. However, most of the knowledge about this comes from studies where patients are evaluated in the hours and up until the first postoperative day. Alternatively, patients are assessed several months (eg 3 or later) after surgery, to evaluate the development of chronic pain related to surgery (CPSP) and most patients do not develop CPSP.

This study aims to learn how patients recover concerning pain and function once they return home after surgery. How long is it before they can resume their daily activities and to do so in comfort? Do they take treatment for pain? Do they have pain restricted to the surgical incision or it is more widespread? There is little knowledge as to whether there are signs of nerve injury in the days close to surgery. This type of pain might lead to chronic pain in later stages.

Patients will be assessed at three time points: the first day after surgery, the 7th day after surgery, and 1 month.

The information we obtain will offer healthcare providers, from multiple hospitals, information about the care they provide to their patients for pain while patients are still in hospital and insights as to how the care might be improved, once they are discharged.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Longitudinal Assessment of Pain-related Patient-reported Outcomes in the Sub-acute Phase After Surgery: a Registry Study From PAIN OUT
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2030
Anticipated Study Completion Date :
Dec 31, 2030

Outcome Measures

Primary Outcome Measures

  1. The difference in pain interference scores between postoperative day 7 (POD7) and 1 month after surgery (POM1). [7th day after surgery (POD7) and 1 Month (M1) after surgery]

    We will assess whether pain-related functional impairment on postoperative day 7 is associated with functional pain-related impairment 1 month after surgery. Functional pain impairment will be assessed using the BPI short-form questionnaire and calculated as a Pain Interference Total Score (PITS) from the 7 interference questions in the BPI. Patients will be allocated to groups of no (PITS=0)/mild-(PITS=1-2)/ moderate /(PITS=2-5) and severe interference (PITS>5). Mean scores of the 2 domains within the functional items, physical interference (general activity, walking ability, and work) and effective interference (mood, enjoyment of life, and relations with other persons) will also be calculated. Sleep will addressed separately as it does not improve psychometric properties of the BPI interference scale. This methodology has been used in another PAIN OUT study, evaluating function at 6 months after surgery (Stamer et al, Pain. 2019 Aug;160(8):1856-1865).

  2. The number of patients with high pain interference on the 7th day after surgery (POD7). [Day 7 after surgery]

    Number of patients with high pain interference at postoperative day 7 (POD7, BPI-PITS >5).

Secondary Outcome Measures

  1. Differences in pain severity (BPI-PSVS, pain severity scale) between postoperative day 7 and 1 month after surgery (POM1). [Day 7 after surgery and Month 1 after surgery]

    We will use the pain severity variables in the BPI to assess pain on postoperative day 7 compared to Month 1 after surgery.

  2. The differences in pain interference (BPI-PITS) between surgical disciplines on postoperative day 7. [Day 7 after surgery]

    This will be a cohort of patients undergoing surgeries from different disciplines. We anticipate that median pain interference scores will not differ between the disciplines.

  3. The differences in pain interference (BPI-PITS) between surgical disciplines at month 1 after surgery. [1 Month after surgery]

    This will be a cohort of patients undergoing surgeries from different disciplines. We anticipate that median pain interference scores will not differ between the disciplines.

  4. The difference in the number of patients with signs of neuropathy on postoperative day 7 between the surgical disciplines. [Day 7 after surgery]

    The difference in the number of patients with signs of neuropathy on postoperative day 7 (DN2 score ≥ 3/7) between the surgical disciplines. Neuropathy will be screened for using the 'Douleur Neuropathique en 2 Questions' (DN2) . Neuropathy is indicated for a score of >3/7 items in the questionnaire (Beloeil et al Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anesthesiology 2017;34:652-7).

  5. The difference in the number of patients with signs of neuropathy at 1 month after surgery (POM1) between the surgical disciplines. [1 Month after surgery]

    The difference in the number of patients with signs of neuropathy at POM1 (DN2 score ≥ 3/7) between the surgical disciplines.

  6. Differences in pain interference scores between patients with vs without signs of neuropathy on postoperative day 7 [Day 7 after surgery]

    Differences in pain interference (BPI-PITS) between patients with vs. without signs of neuropathy (DN2 score ≥ 3/7) on postoperative day 7.

  7. Differences in pain interference (BPI-PITS) between patients with vs. without signs of neuropathy (DN2 score ≥ 3/7) at POM1. [1 Month after surgery]

    Differences in pain interference (BPI-PITS) between patients with vs. without signs of neuropathy (DN2 score ≥ 3/7) at POM1.

  8. Differences in pain severity between patients with vs without signs of neuropathy at POM1 [1 Month after surgery]

    Differences in pain severity (BPI-PSVS) between patients with vs. without signs of neuropathy (DN2 score ≥ 3/7) at POM1.

  9. Assess the difference in the number of patients taking analgesics o POD7 vs POD1. [Day 7 after surgery and 1 Month after surgery]

    The difference in the number of patients taking analgesics between postoperative day 7 and POM1. Patients will be asked if they are taking an analgesic at both time points.

Other Outcome Measures

  1. Exploratory regression analysis for improving understanding of pain interference on day 7 after surgery [First postoperative day and postoperative day 7]

    Exploratory regression analysis for pain interference on postoperative day 7 (BPI-PITS, dependent variable), demographic variables, perioperative treatment variables and patient-reported outcomes (International Pain Out Questionnaire) from the first post-operative day (POD1).

  2. Exploratory regression analysis for improving understanding of pain intensity on postoperative day 7. [First postoperative day and postoperative day 7]

    Exploratory regression analysis for pain intensity on postoperative day 7 (BPI-PSVS, dependent variable). Independent variables will include demographic variables, perioperative treatment variables and patient-reported outcomes obtained on the first postoperative day (POD1)

  3. Exploratory regression analysis for improving understanding of pain intensity at POM1 [First postoperative day and 1 month after surgery]

    Exploratory regression analysis for pain intensity at POM1 (BPI-PSVS, dependent variable). Independent variables will include: demographic variables, perioperative treatment variables and patient reported outcomes (International Pain Out Questionnaire) from the first postoperative day (POD1).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adult

  2. On the first post-operative day and back on the ward for at least 6 hours

  3. Gives consent for assessment at 3-time points

Exclusion Criteria:
  1. The patient is unable to communicate

  2. The patient is cognitively impaired

  3. The patient is asleep

  4. The patient is too ill or in too much pain and does not wish to be interviewed

  5. The patient does not wish to fill in the outcomes questionnaire

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jena University Hospital Jena Germany
2 Hospital Central Militar Mexico City Cdmx Mexico
3 Hospital General de Chihuahua Salvador Zubirán Anchondo El Bajo Chihuahua Mexico
4 Hospital Aranda de La Parra (Leon Guanajuato) León Guanajuato Mexico
5 Hospital San Javier Guadalajara Guadalajara Mexico
6 Centro Nacional SIGLO XXI (IMSS) Mexico City Mexico
7 Hospital Angeles Interlomas CDMX Mexico City Mexico
8 Hospital de traumatologia y Ortopedia Lomas Verdes (IMSS) Mexico City Mexico
9 Hospital fundación Medica Sur Mexico City Mexico
10 Hospital General de Villacoapa (IMSS) Mexico City Mexico
11 Hospital Ruben Leñero Mexico City Mexico
12 Instituto Nacional de Cancerología Mexico City Mexico
13 Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico City Mexico
14 Instituto Nacional de Enfermedades Respiratorias Cosio Villegas (INER) Mexico City Mexico
15 Hospital Angeles Puebla Puebla Mexico
16 Hospital Central Morones Prieto San Luis Potosi San Luis Potosi Mexico

Sponsors and Collaborators

  • Jena University Hospital
  • Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán
  • Centro Medico Nacional Siglo XXI IMSS
  • Hospital de Traumatología y Ortopedia Lomas Verdes
  • Hospital Angeles Puebla
  • Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
  • Hospital Angeles Lomas
  • Hospital San Javier Guadalajara
  • Hospital Aranda de La Parra (Leon Guanajuato)
  • Fundación Clínica Médica Sur
  • Instituto Nacional de Cancerologia de Mexico
  • Hospital General Dr. Ruben Leñero
  • Hospital Central "Dr. Ignacio Morones Prieto"
  • Hospital General Regional Número 2 Dr. Guillermo Fajardo Ortiz
  • Instituto Nacional de Enfermedades Respiratorias
  • Hospital Central Militar

Investigators

  • Principal Investigator: Ana L Garduño López, MD, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
  • Principal Investigator: Vicotor M Acosta-Nava, MD, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
  • Principal Investigator: Ruth Zaslansky, DSc, Jena University Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Ruth Zaslansky, PAIN OUT - scientific director, Jena University Hospital
ClinicalTrials.gov Identifier:
NCT05315596
Other Study ID Numbers:
  • JenaUH_pain
First Posted:
Apr 7, 2022
Last Update Posted:
Apr 7, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2022